IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oracle Investment Management Inc

Q4 2024 Holdings

Filed 2025-02-14 | 19 holdings | $183.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Genedx Holdings Corp(WGS)COM CL A81663L200$78.7M1,023,46842.8%
Biohaven LTD(BHVN)COMG1110E107$31.8M851,77017.3%
Select Sector Spdr TRPutPUT81369Y959$15.8M115,0008.6%
Ardelyx Inc(ARDX)COM039697107$10.6M2,089,4315.8%
Springworks Therapeutics IncCOM85205L107$9.2M254,7735.0%
Biohaven LTD(BHVN)CallCALLG1110E907$7.5M200,0004.1%
Quidelortho Corp(QDEL)COM219798105$5.3M118,2912.9%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$4.0M535,5582.2%
Novavax IncCallCALL670002901$3.7M466,0002.0%
Ardelyx IncCallCALL039697907$3.0M584,7001.6%
Forian Inc(FORA)COM34630N106$2.8M1,366,1071.5%
Teladoc Health IncCallCALL87918A905$2.7M297,7001.5%
Palantir Technologies Inc(PLTR)CL A69608A108$2.2M28,5001.2%
Cava Group Inc(CAVA)COM148929102$2.1M18,6001.1%
Springworks Therapeutics IncCallCALL85205L907$2.0M55,8001.1%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$1.2M145,0640.6%
Pacific Biosciences Calif in(PACB)COM69404D108$511.7K279,6380.3%
Biogen Inc(BIIB)COM09062X103$368.8K2,4120.2%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$242.1K32,5000.1%